Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Nicolau

Showing results (11-20 of 632) with videos related to

Pageof 64
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2008
Pharmacokinetic and pharmacodynamic properties of meropenemDavid P Nicolau
Expert Opinion on Pharmacotherapy|May 2, 2009
Management of complicated infections in the era of antimicrobial resistance: the role of tigecyclineDavid P Nicolau
Journal of Managed Care Pharmacy : JMCP|June 10, 2009
What is the 360-degree approach to defining success for VAP?David P Nicolau
The Journal of Antimicrobial Chemotherapy|January 14, 2023
In vivo pharmacokinetic/pharmacodynamic evaluation of cefepime/taniborbactam combination against cefepime-non-susceptible Enterobacterales and Pseudomonas aeruginosa in a murine pneumonia modelKamilia Abdelraouf, David P Nicolau
Future Microbiology|May 29, 2008
Oritavancin: a potential weapon in the battle against serious Gram-positive pathogensJared Crandon, David P Nicolau
Current Opinion in Infectious Diseases|January 25, 2017
Obesity and skin and soft tissue infections: how to optimize antimicrobial usage for prevention and treatment?Mordechai Grupper, David P Nicolau
Expert Review of Anti-Infective Therapy|May 6, 2020
Precision medicine for the diagnosis and treatment of carbapenem-resistant Enterobacterales: time to think from a different perspectiveSergio Reyes, David P Nicolau
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 30, 2007
Development of an HPLC method for the determination of doripenem in human and mouse serumChristina Sutherland, David P Nicolau
Antimicrobial Agents and Chemotherapy|November 2, 2016
Comparative In Vivo Efficacies of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection ModelsKamilia Abdelraouf, David P Nicolau
Journal of the American Medical Directors Association|July 12, 2003
Evolving epidemiology and cost of resistance to antimicrobial agents in long-term care facilitiesBlair Capitano, David P Nicolau
Pageof 64

Showing results (11-20 of 632) with videos related to

Sort By:
Pageof 64
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2008
Pharmacokinetic and pharmacodynamic properties of meropenemDavid P Nicolau
Expert Opinion on Pharmacotherapy|May 2, 2009
Management of complicated infections in the era of antimicrobial resistance: the role of tigecyclineDavid P Nicolau
Journal of Managed Care Pharmacy : JMCP|June 10, 2009
What is the 360-degree approach to defining success for VAP?David P Nicolau
The Journal of Antimicrobial Chemotherapy|January 14, 2023
In vivo pharmacokinetic/pharmacodynamic evaluation of cefepime/taniborbactam combination against cefepime-non-susceptible Enterobacterales and Pseudomonas aeruginosa in a murine pneumonia modelKamilia Abdelraouf, David P Nicolau
Future Microbiology|May 29, 2008
Oritavancin: a potential weapon in the battle against serious Gram-positive pathogensJared Crandon, David P Nicolau
Current Opinion in Infectious Diseases|January 25, 2017
Obesity and skin and soft tissue infections: how to optimize antimicrobial usage for prevention and treatment?Mordechai Grupper, David P Nicolau
Expert Review of Anti-Infective Therapy|May 6, 2020
Precision medicine for the diagnosis and treatment of carbapenem-resistant Enterobacterales: time to think from a different perspectiveSergio Reyes, David P Nicolau
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 30, 2007
Development of an HPLC method for the determination of doripenem in human and mouse serumChristina Sutherland, David P Nicolau
Antimicrobial Agents and Chemotherapy|November 2, 2016
Comparative In Vivo Efficacies of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection ModelsKamilia Abdelraouf, David P Nicolau
Journal of the American Medical Directors Association|July 12, 2003
Evolving epidemiology and cost of resistance to antimicrobial agents in long-term care facilitiesBlair Capitano, David P Nicolau
Pageof 64